Key result
Polypharmacy was present in 28.6% of elderly patients and was associated with the use of antihypertensives, antidiabetics, or lipid-lowering agents.
Why the study?
The study was conducted to estimate the prevalence of cardiometabolic diseases and evaluate their association with polypharmacy among elderly individuals attending the University of the Third Age.
Cross-Sectional (n=121)
In an elderly cohort, there is a high prevalence of cardiometabolic diseases and associated polypharmacy, highlighting a reliance on pharmacotherapy over lifestyle changes.
Answers are grounded in this paper and cite their sources.
High cardiometabolic burden signals need for screening in active elderly; leaves open polypharmacy causality pending longitudinal data.
OBJECTIVES: To estimate the prevalence of cardiometabolic diseases and their association with polypharmacy in elderly people at the University of the Third Age (Portuguese acronym: UnATI). METHODS: A cross-sectional, descriptive, analytical study with 121 elderly patients. The prevalence ratio, Pearson's Chi-square test and Fisher's exact test were used as measures of association. RESULTS: At the mean age of 68.3, most elderly had at least one cardiometabolic disease (82.6%), of which hypertension was the most prevalent (71.1%), and consumed prescription drugs of continuous use (92.6%). Almost half of the elderly (48.2%) used combinations of drugs, which suggests a high cardiovascular risk. Polypharmacy due to prescription was observed in almost one-third (28.6%) of the sample, associated with the use of antihypertensives (p=0.004), antidiabetics (p=0.000) or lipid-lowering agents (p<0.000). CONCLUSIONS: Clinical guidelines recommend changes in lifestyle, but increased pharmacotherapy prevails in practice, which increases the risk of adverse events, especially in old age.
No takes yet. Share an insight, caveat, or question.
Santos et al. (2020) conducted a cross-sectional in Cardiometabolic diseases and polypharmacy (n=121). Cardiometabolic diseases and prescription drug use was evaluated on Prevalence of cardiometabolic diseases and their association with polypharmacy. Polypharmacy was present in 28.6% of elderly patients and was associated with the use of antihypertensives, antidiabetics, or lipid-lowering agents.
Synapse has enriched 10 related papers. Consider them for comparative context: